3 ms·
Most of the costs of bringing a new drug to market are in the human trials. Sure pre-clinical is expensive, but it's still super cheap compared to clinical dev
by refurb 7y ago
Most of the costs of bringing a new drug to market are in the human trials. Sure pre-clinical is expensive, but it's still super cheap compared to clinical development.
So if this drug you discovered does make it to market, the drug company itself is paying for the vast majority of the costs and all the risk that goes along with spending hundreds of millions and having nothing to show for it. In return, we dangle the carrot of profit in front of them.
You are correct that the public paid for that initial discovery, but the ownership is given to the lab that found it. The other alternative is for the gov't to keep ownership of the patent.